Conversation with The Cancer Letter Pavan Reddy tells us how his research dovetails with running Baylor’s Dan L Duncan cancer center November 04, 2022Vol.48 No.40By Paul Goldberg
Conversation with The Cancer Letter Children’s National and UCL team receives $25M Grand Challenges award to study CAR T in pediatric solid tumors November 04, 2022Vol.48 No.40By Jacquelyn Cobb
Conversation with The Cancer Letter ChristianaCare explores using CRISPR in cancer treatment, starts talks with FDA October 21, 2022Vol.48 No.38By Paul Goldberg
Conversation with The Cancer Letter Fred Hutch receives $710.5M from Bezos family to speed up clinical trials, translational research, recruitmentGift is part of a 10-year $3B fundraising effort October 14, 2022Vol.48 No.37By Paul Goldberg
Cancer History ProjectConversation with The Cancer Letter Viral oncology’s complicated path—from cancer as contagion to today’s immunotherapy October 14, 2022Vol.48 No.37By Alexandria Carolan
Conversation with The Cancer Letter Thyme Care founders talk about the business of patient navigation October 07, 2022Vol.48 No.36By Paul Goldberg
Conversation with The Cancer Letter Ben Ho Park wants Vanderbilt to deliver precision oncology in Tennessee—and globally September 30, 2022Vol.48 No.35By Paul Goldberg
Conversation with The Cancer Letter 25M Americans live outside cancer centers’ catchment areas, AACI-Jefferson study finds September 30, 2022Vol.48 No.35By Matthew Bin Han Ong
Conversation with The Cancer Letter Jefferson’s Andrew Chapman tells us what it’s like to be the first geriatric oncology expert to run a cancer center September 23, 2022Vol.48 No.34By Paul Goldberg
Conversation with The Cancer Letter FDA spells out new systematic approach to giving out–and taking away–accelerated approvals in oncology September 23, 2022Vol.48 No.34By Paul Goldberg
